WHO Global Surveillance and Monitoring System for substandard and falsified medical products

by Elizabeth Pisani, Suzanne Hill, Emer Cooke et al.
WHO Global Surveillance and Monitoring System (GSMS) for substandard and falsified medical products, 2017

73 pp. 6.2 MB
http://www.who.int/entity/medicines/regulation/ssffc/publications/GSMS_Report.pdf?ua=1

WHO launched its Global Surveillance and Monitoring System for substandard and falsified medicines, vaccines and in-vitro diagnostic tests in July 2013. This first report is based on data collected during the first 4 years of operation up to 30 June 2017. The report has grown out of the work of the GSMS, which provides national regulatory authorities with an interconnected network. This allows them, for the first time, to cross-reference reports of suspect products with those reported from other regions by searching the WHO database and accessing photograph libraries of confirmed substandard and falsified products.

(Visited 8 times, 1 visits today)
This entry was posted in Essential Medicines, General, Global Health. Bookmark the permalink.